Revision Notes On Biotechnology Principles and Processes NEET 2023 - Free PDF Download
Revision Notes On Biotechnology Principles and Processes NEET 2023 - Free PDF Download
Revision Notes On Biotechnology Principles and Processes NEET 2023 - Free PDF Download
Biology
Biotechnology: Principles and Processes
Introduction
Biotechnology can be defined as the use of microorganisms, animals, or
plant cells, or their products, to produce a variety of products and services
that are valuable to humans on an industrial scale.
Traditional biotechnology relied on microorganism’s inherent abilities.
For example, Citric acid is produced by Penicillium notatum, while
Penicillin is produced by Penicillium notatum.
Recombinant DNA technology is the heart of new biotechnology. A human
gene that produces insulin, for example, has been transferred and expressed
in bacteria such as Escherichia coli.
Microbiology, biochemistry, tissue culture, chemical engineering and
genetic engineering, molecular biology, and immunology are all used in
modern biotechnology to create a variety of valuable products.
Genetic Engineering:
One type of biotechnology that involves DNA manipulation is genetic
engineering (also known as recombinant DNA technology or gene splicing). It is
concerned with the isolation of relevant genes from various sources as well as the
production of novel DNA combinations (recombinant DNA) for genotype repair,
improvement, perfection, and matching.
Genetic engineering is a technique for artificially and purposefully altering
DNA (genes) to meet human requirements.
Breaking a DNA molecule at two specified locations with the help of
restriction endonuclease to extract a specific DNA segment and then
inserting it in another DNA molecule at a desired position is used in genetic
engineering to manipulate it.
Recombinant DNA is the new DNA molecule, and genetic engineering is
the technique. The goal of genetic engineering is to add, remove, or repair
a piece of genetic material.
Cloning Vector
Vehicle or vector DNA is the DNA that is employed as a carrier for introducing
a segment of foreign DNA into a suitable host. Plasmids and bacteriophages can
reproduce in bacterial cells without the help of chromosomal DNA.
● The following are the characteristics that must be present in order for
cloning into a vector to be possible.
● Replication's starting point (Ori): This is the sequence in which replication
begins. For the vector DNA to divide within the host cells to produce its
more copies, it needs an origin of replication (ori). This sequence is also in
charge of regulating the quantity of copies of linked DNA. This means that
any foreign DNA introduced into the vector will be replicated during the
replication phase.
Cloning sites: The vector requires recognition sites for commonly used
restriction enzymes in order to link the alien DNA. A restriction site located in
one of the two antibiotic resistance genes is used to ligate foreign DNA. For
example, with the vector pBR322, you can ligate a foreign DNA at the BamHI
site of the tetracycline resistance gene. Due to the inclusion of foreign DNA, the
recombinant plasmids will lose their tetracycline resistance (insertional
inactivation). It may now be distinguished from non-recombinant transformants
by plating transformants on ampicillin-containing media. After growing on
ampicillin-containing media, the transformants (plasmid transfer) are moved to a
tetracycline-containing medium. In the ampicillin-containing medium, the
recombinants will grow, but not in tetracycline-containing medium. Non-
recombinants, on the other hand, will grow on a medium containing both
antibiotics. One antibiotic resistance gene aids in the selection of transformants
in this circumstance.
Selection of recombinants is a difficult method due to antibiotic inactivation, as
it necessitates simultaneous plating on two plates with different antibiotics. As a
result, alternative selectable markers that distinguish recombinants from non-
recombinants based on their ability to produce colour in the presence of a
chromogenic substrate have been devised. Insertional inactivation is a technique
that involves inserting recombinant DNA into an enzyme's coding sequence. If
the plasmid in the bacterium does not include an insert, the presence of the
chromogenic substrate X-gal (5-bromo-4, chloro—D galactopyranoside) results
in blue colonies. The presence of an insert causes the -galactosidase (reporter
enzyme) to be inactivated, and the colonies do not produce any colour, identifying
them as recombinant colonies.
Viruses: Certain viruses have DNA that can be used as a vehicle DNA. The genes
for galactosidase were transferred from Escherichia coli to human cells using a
bacteriophage (bacterial virus). Lambda phage (phage) was utilised to transfer lac
genes from E. coli to tomato haploid callus.
Note:
Plasmid 0.5-8
Cosmid 30-45
BAC 50-300
YAC 1000-2500
Passenger DNA: It is the DNA that is combined with the vehicle DNA and
transported from one organism to another. Complementary, synthetic, or random
DNA can be used as a passenger.
● Complementary DNA (cDNA) is created using reverse transcriptase and
the required nucleotides on an mRNA template.
● Synthetic DNA (sDNA) is created on a DNA template with the help of
DNA polymerase.
● Random DNA refers to tiny pieces created when restriction endonucleases
are used to break a chromosome.
Recombinant DNA molecules are created with one of three goals in mind:
● To get a lot of copies of a certain DNA segment,
● To recover a large amount of the protein generated by the gene in question.
● To integrate the gene in issue into a target organism's genome, where it can
express itself.
Genetic engineering was used to develop this approach. First, the desired gene is
isolated from any creature and then transferred and expressed into the organism
of choice. These are known as transgenic organisms. In order to obtain novel
therapeutic proteins, transgenic microbes are created.
Human insulin, for example, is commercially produced from a transgenic E.coli
strain.
Transgenic animal cell lines and transgenic plants are also used to make a variety
of useful recombinant proteins.
At the same time, non-transgenic cells or organisms could not manufacture a
number of these important medical proteins on a commercial scale. Recombinant
proteins are proteins created by transgenes. Recombinant genes of this type are
used to create a variety of products.
Downstream Process:
After the biosynthetic stage is completed, the product must go through a series of
processes before it can be sold as a finished product. Separation and purification
are among the procedures, which are referred to as downstream processing.
Preservatives must be included in the product's formulation.